Adjusting Basal Insulin for Optimal Glucose Control
Start basal insulin at 10 units once daily (or 0.1-0.2 units/kg/day), then increase by 2 units every 3 days until fasting plasma glucose reaches 80-130 mg/dL, reducing the dose by 10-20% if hypoglycemia occurs. 1
Initial Dosing Strategy
- Begin with 10 units once daily OR 0.1-0.2 units/kg/day for insulin-naive patients with type 2 diabetes, administered at the same time each day 1, 2
- For patients with more severe hyperglycemia (A1C ≥9% or blood glucose ≥300 mg/dL), consider higher starting doses of 0.3-0.4 units/kg/day 1, 2
- For type 1 diabetes, total daily insulin is typically 0.4-1.0 units/kg/day, with approximately 50% as basal insulin 1, 2
Evidence-Based Titration Algorithm
The core titration approach follows a systematic 3-day cycle:
- Increase by 2 units every 3 days if fasting glucose is 140-179 mg/dL 1, 3
- Increase by 4 units every 3 days if fasting glucose is ≥180 mg/dL 1, 2
- Continue titration until fasting plasma glucose reaches target of 80-130 mg/dL 1, 2
- If hypoglycemia occurs without clear cause, reduce dose by 10-20% immediately 1, 3
This algorithm can be implemented even when patients are concurrently receiving short-acting insulin (sliding scale) three times daily, as basal and correctional insulin operate independently 2
Critical Threshold: Recognizing Overbasalization
Stop escalating basal insulin when the dose exceeds 0.5 units/kg/day and consider adding adjunctive therapy instead 1, 3
Clinical signals of overbasalization include: 1, 2
- Basal insulin dose >0.5 units/kg/day
- Bedtime-to-morning glucose differential ≥50 mg/dL
- Hypoglycemia (aware or unaware)
- High glucose variability
- Elevated postprandial-to-preprandial glucose differential
When these signs appear, add prandial insulin or a GLP-1 receptor agonist rather than continuing to increase basal insulin 1, 3
Advancing Beyond Basal-Only Therapy
When to Add Prandial Insulin
If A1C remains above goal after 3-6 months despite achieving fasting glucose targets, or if basal insulin approaches 0.5-1.0 units/kg/day: 1, 2
- Start with 4 units of rapid-acting insulin before the largest meal OR 10% of current basal dose 1, 2
- Increase prandial insulin by 1-2 units or 10-15% every 3 days based on postprandial glucose readings 1, 2
- Add prandial insulin to additional meals stepwise as needed 1
Alternative: GLP-1 Receptor Agonist
If not already on a GLP-1 RA or dual GIP/GLP-1 RA, consider adding these agents in combination with basal insulin (fixed-ratio products available) 1
Special Situations
Steroid-Induced Hyperglycemia
- Use morning NPH insulin rather than long-acting analogs to match the afternoon/evening hyperglycemic pattern from steroids 4
- Dose NPH at 0.3-0.4 units/kg in the morning for patients on high-dose steroids 4
Hospitalized Patients
- For insulin-naive hospitalized patients, start with 0.3-0.5 units/kg/day total daily dose, giving half as basal insulin 2
- For patients on high-dose home insulin (≥0.6 units/kg/day), reduce total daily dose by 20% upon hospitalization to prevent hypoglycemia 2
Switching Between Basal Insulins
- Generally use a unit-to-unit conversion when switching from NPH to long-acting analogs (glargine, detemir, degludec) 5, 6, 7
- Some patients with type 2 diabetes may require more insulin detemir than NPH (mean doses 0.77 U/kg vs 0.52 U/kg in clinical trials) 5
Monitoring Requirements
- Daily fasting blood glucose monitoring is essential during titration 2, 3
- Assess adequacy of insulin dose at every clinical visit 1, 3
- Look for clinical signals of overbasalization at each assessment 1, 3
- For ultra-long-acting insulins (degludec), some experts recommend waiting at least 1 week before subsequent dose adjustments 2
Common Pitfalls to Avoid
- Never continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia—this leads to suboptimal control and increased hypoglycemia risk 2
- Do not wait longer than 3 days between basal insulin adjustments in stable patients, as this unnecessarily prolongs time to glycemic targets 2
- Avoid delaying insulin initiation in patients not achieving glycemic goals with oral medications 2
- Do not ignore the need for prandial insulin when signs of overbasalization are present 2
- Continue metformin when adding or intensifying insulin therapy unless contraindicated 1, 2